1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alliance A061202. A phase I/II study of pomalidomide, dexamethasone and ixazomib versus pomalidomide and dexamethasone for patients with multiple myeloma refractory to lenalidomide and proteasome inhibitor based therapy: Phase I results
    Meeting Abstract

    Voorhees, P. M.; Mulkey, F.; Hassoun, H.; Paba-Prada, C. E.; Efebera, Y. A.; Hoke, E.; Aquino, G.; Carlisle, D.; Suman, V.; Richardson, P. G.
    Blood (2015)

    Fulltext@MSK | Save
  • Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis
    Meeting Abstract

    Viny, A. D.; Ott, C. J.; Spitzer, B.; Rivas, M. A.; Meydan, C.; Papalexi, E.; Yelin, D.; Shank, K.; Reyes, J.; Chiu, A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • An integrative genomics approach uncovers the basis of resistance to AZA therapy in MDS and CMML
    Meeting Abstract

    Unnikrishnan, A.; Papaemmanuil, E.; Beck, D.; Verma, A.; Kumari, A.; Richards, L. A.; Knezevic, K.; Chandrakanthan, V.; Thoms, J. A. I.; Tursky, M. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Bantilan, K. S.; Verwys, S. L.; McCall, S. J.; Yahalom, J.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Marqibo®, vincristine sulfate liposome injection, for the treatment of advanced, relapsed or refractory Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in an adolescent young adult (AYA) population
    Meeting Abstract

    Schiller, G. J.; Damon, L. E.; Stock, W.; Coutre, S. E.; Hsu, P.; Prasad, L.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • A phase 1 trial of SGN-CD33A as monotherapy in patients with CD33-positive acute myeloid leukemia (AML)
    Meeting Abstract

    Stein, A. S.; Walter, R. B.; Erba, H. P.; Fathi, A. T.; Advani, A. S.; Lancet, J. E.; Ravandi, F.; Kovacsovics, T. J.; DeAngelo, D. J.; Bixby, D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The multi-kinase inhibitor midostaurin (M) prolongs survival compared with placebo (P) in combination with daunorubicin (D)/cytarabine (C) induction (ind), high-dose C consolidation (consol), and as maintenance (maint) therapy in newly diagnosed acute myeloid leukemia (AML) patients (pts) age 18-60 with FLT3 mutations (muts): An international prospective randomized (rand) P-controlled double-blind trial (CALGB 10603/RATIFY [Alliance])
    Meeting Abstract

    Stone, R. M.; Mandrekar, S.; Sanford, B. L.; Geyer, S.; Bloomfield, C. D.; Dohner, K.; Thiede, C.; Marcucci, G.; Lo-Coco, F.; Klisovic, R. B.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • From T-cell engineering to CAR therapy: Progress and prospects
    Meeting Abstract

    Sadelain, M.
    Blood (2015)

    Fulltext@MSK | Save
  • A prognostic system predictive of outcomes in persons undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Meeting Abstract

    Shaffer, B. C.; Ahn, K. W.; Hu, Z. H.; Popat, U. R.; Kalaycio, M.; Maziarz, R. T.; Alyea, E.; Sobecks, R. M.; Pavletic, S. Z.; Tallman, M. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Recurrent mutations in CCND3 confer clinical resistance to FLT3 inhibitors
    Meeting Abstract

    Smith, C. C.; Viny, A. D.; Massi, E. S.; Kandoth, C.; Socci, N. D.; Hsu, H.; West, B.; Bollag, G.; Taylor, B. S.; Levine, R. L.; more...
    Blood (2015)

    Fulltext@MSK | Save